Johnson and Johnson

Johnson & Johnson Wins Big Court Battle

J.C. Penney today opens its first store-within-the-store boutiques. They'll offer home goods from designers such as Michael Graves, Jonathan Adler and Sir Terence Conran.

Does Johnson & Johnson Need a Lot More than Just a Band-Aid?

Everyone knows Johnson & Johnson, but not everyone knows how big this pharmaceutical and medical device giant really is. And they also may not realize how much it's recent series of drug recalls and management missteps have pummeled the blue chip stock.

FDA Revisits Safety of Newer Birth Control Drugs

Birth control drugs that were heavily promoted as having fewer side effects are now under scrutiny from the FDA in the wake of new research suggesting that they are more likely to cause blood clots than older drugs.

Top-Selling Drugs About to Lose Patent Protection

The pharmaceutical industry is about to fall off a cliff -- a patent cliff. Over the next few years, some of the world's most popular and lucrative medicines will go off patent, and generic competition will siphon an estimated quarter of a trillion dollars from companies' bottom lines. Here's a rundown:

Johnson & Johnson Recalls Sudafed Because of a Typo

"Do not not divide, crush, chew, or dissolve the tablet," reads the label on packages of Johnson & Johnson's Sudafed allergy and cold medicine. The company is recalling 667,632 packages for the typographical error.

What a Wild Year It Was
for Health Care

Led by the health insurance reform law, a flurry of drug and food recalls, key medical breakthroughs and plenty of layoffs and lawsuits, 2010 proved to be an exciting -- if not always positive -- year. Here's our list of the year's biggest health stories.

Ortho Ordered to Pay $1.7 Million in Levaquin Lawsuit

On Wednesday, a Minneapolis jury ordered Johnson & Johnson subsidiary Ortho-McNeil-Janssen Pharmaceuticals to pay an 87-year-old man $1.7 million because its antibiotic Levaquin damaged his Achilles tendons. It was the first verdict from about 2,600 similar lawsuits filed so far.

Johnson & Johnson Recalls Mylanta Over Labeling

If you get the feeling Johnson & Johnson is recalling products every day, you wouldn't be that far from the truth. Now it's dragging Merck with it as the two announced a recall of 12 over-the-counter Mylanta heartburn medicine liquid products as well as Alternagel liquid antacid to update product labeling.

Can GE and J&J Help Detect Alzheimer's Earlier?

Medical imaging and diagnostics powerhouse GE Healthcare teams up with pharmaceutical giant Johnson & Johnson to research methods of detecting Alzheimer's in patients -- even before they begin to exhibit symptoms of the devastating disease.

J&J Earnings Hurt by Children's Medicine Recalls

Tylenol and Band-Aid maker Johnson & Johnson announced on Tuesday that its sales declined 0.7% to $15 billion in the third quarter, compared to the same quarter last year, as domestic sales were "significantly impacted" by recent successive recalls. Domestic sales declined 2.5%.

Johnson & Johnson Recalls Tylenol Products on Odor Complaints

Johnson & Johnson (JNJ) is recalling Tylenol products because of a musty odor, the company%u2019s third such recall in 12 months. J&J is yanking a line of Tylenol 8-hour caplets containing 127,728 bottles after customers complained of a musty smell from the pills, Bloomberg News said. The smell may be related to a chemical that is applied to wooden pallets used to store packing materials.

J&J Apologizes for Kids Medicine Issues, Phantom Recalls

In testimony before Congress Thursday, Johnson & Johnson's CEO apologized for the problems that have beset his company, including the quality issues with its children's medicines and the "phantom recall" of a batch of Motrin. He also said new batches of its children's medicines should start shipping next week.